➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
AstraZeneca
Boehringer Ingelheim
McKinsey
McKesson

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for FG-4592


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug FG-4592?

FG-4592 is an investigational drug.

There have been 26 clinical trials for FG-4592. The most recent clinical trial was a Phase 2 trial, which was initiated on June 11th 2019.

The most common disease conditions in clinical trials are Anemia, Kidney Diseases, and Renal Insufficiency, Chronic. The leading clinical trial sponsors are FibroGen, Astellas Pharma Europe B.V., and AstraZeneca.

There are forty-nine US patents protecting this investigational drug and three hundred and seventy-eight international patents.

Recent Clinical Trials for FG-4592
TitleSponsorPhase
Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKDAstraZenecaPhase 3
Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKDFibroGenPhase 3
Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia and Risks of Cardiovascular and Cerebrovascular Events in ESRD Newly Initiated Dialysis PatientsSecond Xiangya Hospital of Central South UniversityPhase 4

See all FG-4592 clinical trials

Clinical Trial Summary for FG-4592

Top disease conditions for FG-4592
Top clinical trial sponsors for FG-4592

See all FG-4592 clinical trials

US Patents for FG-4592

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
FG-4592   Try Before You Buy Nitrogen-containing heteroaryl compounds and methods of use thereof FibroGen, Inc. (San Francisco, CA)   Try Before You Buy
FG-4592   Try Before You Buy Crystalline forms of a prolyl hydroxylase inhibitor FibroGen, Inc. (San Francisco, CA)   Try Before You Buy
FG-4592   Try Before You Buy Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Dow
Johnson and Johnson
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.